Athena Athena

X

Find the latest Drugs in Development and Pipeline Prospector News of Ohara Pharmaceutical.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ohara Pharmaceutical
japan Flag
Country
Country
Japan
Address
Address
36F St. Luke's Tower, 8-1 Akashi-cho, Chuo-ku, Tokyo 104-6591
Telephone
Telephone
+81-3-6740-7701
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Voraxaze® is a carboxypeptidase indicated to reduce toxic plasma methotrexate concentration (greater than 1 micromole per liter) in adult and pediatric patients with delayed methotrexate clearance due to impaired renal function.


Lead Product(s): Glucarpidase

Therapeutic Area: Pharmacology/Toxicology Product Name: Megludase

Highest Development Status: ApprovedProduct Type: Small molecule

Partner/Sponsor/Collaborator: BTG Specialty Pharmaceuticals

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable September 28, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY